Evolvere BioSciences is a startup based in the United Kingdom, most recent round Seed, 1 tracked investor.
Based in the United Kingdom, Evolvere BioSciences is a startup. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Evolvere BioSciences develops next-generation antibiotics using computational models and AI to forecast bacterial mutations and design therapies that precisely target pathogenic bacteria while sparing beneficial microbes and human cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.